# The decline in cardiovascular diseases # --- [](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## Cardiovascular Disease Feet ## Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo. Cardiovascular diseases and their impact on the feet Cardiovascular diseases represent one of the most important health challenges of the 21st century. This century. They include a wide range of diseases that affect the heart and the vascular system, including atherosclerosis, hypertension, coronary heart disease and peripheral arterial occlusive disease (paod). Special attention should be paid to the impact of this disease on the lower limbs, particularly the feet. A Central role of the peripheral arterial occlusive disease (paod), in which there is a narrowing or blockage of the arteries of the legs plays here. This leads to reduced blood flow, which Go in symptoms such as intermittent Klaudikation (pain when, after a short Pause decay), sensitivity to cold and paleness of the feet manifests. In the case of progressive disease, it may even lead to Gewebsschädigungen and ulcers (sores) on the soles of the feet or toes. Another important aspect is venous insufficiency, which is often associated with cardiovascular problems. In this disease, the venous valves are not functioning sufficiently, which leads to a backflow of blood in the legs. Typical symptoms of Edema (swelling), varices (varicose veins) and a change in skin pigmentation of the feet and calves are. In the long term, this can lead to stasis dermatitis and venous ulcers. Particularly patients with Diabetes mellitus are at risk, because in them the cardiovascular occurrence of diseases frequently, and in addition, a neuropathic injury. This reduces the perception of pain, causing minor injuries to stay on the feet unnoticed and develop serious complications, such as diabetic foot ulcers can. Diagnostic measures for the evaluation of cardiovascular-related foot problems include: Ankle‑Brachial Index (ABI) for the assessment of the blood circulation; Doppler ultrasound for the visualization of vascular changes; Blood tests to Check the risk factors such as cholesterol and blood sugar; optionally angiography for a detailed presentation of the arteries. Therapeutic approaches depend on the particular disease and can include the following measures: drug therapy (e.g. anticoagulants, vasodilators); The style changes (quitting Smoking, regular physical activity) life; surgical interventions (e.g., Bypass surgery, angioplasty); special foot care and orthotics in patients with diabetes. In summary, it is shown that cardiovascular diseases can have a significant impact on the health of the feet. Early diagnosis and adequate therapy are, therefore, essential to prevent complications and to maintain the quality of life of those Affected. I have two stents inserted in my heart and have been dealing with nerve-wracking irregular heartbeat my whole life. I decided to give Cardio Balance a try, and I thank God for it! Just after using it for a couple of weeks, my irregular heart beating became normal. I feel more ALIVE, young, and energetic. > Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat.  <a href="https://md.gafert.org/s/4_277EEvy">The decline in cardiovascular diseases</a> With Cardio Balance supplement, you can enjoy the peace of mind that comes with taking control of your cardiovascular health. All the natural ingredients are expertly combined in the right dosages to support all your organs, ensuring they receive the necessary nutrients to function optimally. This all-natural solution helps regulate blood pressure and cholesterol levels without the fear of adverse side effects, empowering you to live your best life. <a href="https://hedgedoc.auro.re/s/Ve_t3cj_VM">PUMUNTA SA WEBSITE>>> </a> The decline in cardiovascular diseases: causes and prospects In the last few decades, there has been in many developed countries, a significant decline in mortality due to cardiovascular disease (CVD). This Trend is the result of a combination of medical advances, preventative measures, and social changes. One of the most important factors for the reduction of CVD mortality, the improvement of diagnostic and therapeutic methods. The development of effective drugs — such as statins to lower cholesterol, antihypertensive drugs to control blood pressure, as well as anticoagulants for the prevention of thrombosis has improved the prognosis for patients with cardiovascular risk factors. In addition, invasive procedures such as coronary angiography, Percutaneous Coronary Intervention (PCI) and coronary Bypass surgery have revolutionized the treatment of acute heart attacks and coronary heart disease. Another important aspect is the prevention. Health campaigns aimed at the reduction of risk factors, play a Central role. These risk factors include: Smoking unhealthy diet, lack of physical activity, Overweight and obesity, chronically elevated blood pressure (hypertension), Diabetes mellitus. Through public awareness and political measures (such as tobacco tax increases, Werarkungsstandards and promotion of sports offered) could be reduced in many regions, the prevalence of these risk factors. For example, studies show that the number of smokers in Europe has decreased in the last 30 years, significant, which has directly contributed to the reduction of heart attacks and strokes. In addition, it has spread the awareness for a healthy way of life. The introduction of Screening programmes for the early detection of hypertension, hypercholesterolemia and Diabetes, and allows for early Intervention and thus prevention of serious consequences. Despite these positive developments, challenges remain, however. In some population groups, particularly in socially disadvantaged strata of society, the incidence of CVD remains high. In addition, the prevalence of obesity and Diabetes in some regions, continue to rise, which could threaten the long-term progress in the reduction of CVD. In summary, one can say that the decline in cardiovascular disease is due to a combination of medical advances, more effective prevention and social awareness. In order to secure this positive development in the long term, however, continuous investments in research, health promotion and social equality is required. Would you like me to make a certain section in more detail or additional aspects into account? ## Medicines for kidneys-high blood pressure ## Medicines for kidneys-high blood pressure: An important step for health care High blood pressure, medically called hypertension, is one of the most common health problems in modern societies. A special Form of renal hypertension (renal hypertension), in which the function of the kidney is directly related to the increased blood pressure is. This disease poses a double challenge: not only does it harm the cardiovascular System, but also the kidney itself can destroy gradually. What is kidney causes high blood pressure? The kidneys-high blood pressure is often caused by interference in the Renin‑Angiotensin‑aldosterone‑System (RAAS), which plays an important role in the Regulation of blood pressure and Fluid balance. Other triggers are: Renal Vascular Stenosis (Renovascular Hypertension); chronic kidney disease; inflammatory processes in the kidneys. Without adequate treatment, can develop the disease, to severe complications from heart attacks and strokes and to kidney failure. What medications are used? The us is the most important therapeutic strategies for renal-hypertension drug treatment. Doctors use various drug groups, which differ in their mode of action: ACE inhibitors (Angiotensin‑Converting enzyme inhibitors): they inhibit the formation of Angiotensin II, a potent Blood vasoconstrictor, and reduce blood pressure. Examples: Enalapril, Ramipril. AT1‑receptor blockers (Sartans): These drugs block the action of Angiotensin II at the receptor and cause vessels to a relaxation of the blood. Representative: Losartan, Valsartan. Diuretics (diuretics): they promote the excretion of salt and water by the kidney and reduce the volume of blood. Examples: Hydrochlorothiazide, Furosemide. Calcium channel blockers: they facilitate the flow of blood through a relaxation of the smooth muscle in the vessel walls. To do this, amlodipine and nifedipine include. Beta-blockers: decrease the heart rate and the force of heart muscle contractions, and are particularly in patients with concomitant heart problems useful (Metoprolol, Bisoprolol). Individual therapy — the key to success There is no cure-all for kidney high blood pressure. The choice of drugs depends on: the degree of blood pressure increase; the other diseases (Diabetes, heart failure) are Present; the renal function (as measured by the glomerular filtration rate); possible side effects. Often, a combination therapy of two or more substances is applied to the blood pressure effectively and to protect the kidneys. Lifestyle changes as an important support Medications alone are often not enough. A healthy lifestyle is an important part of the treatment: Reduction of salt consumption; sufficient physical activity; a healthy diet with lots of vegetables and fruit; Avoiding Smoking and excessive alcohol consumption; Weight control. Conclusion Drug therapy in renal-hypertension is a complex, but promising way to protect the health of the patients in the long term. Through a tailored combination of modern medicines and health-promoting lifestyle habits, blood pressure values stabilize and follow-up to prevent damage to the heart and kidneys. A prerequisite for early diagnosis and close cooperation between the physician and the Patient, however. <a href="https://doc.gnuragist.es/s/7836qrVt42">Presentation on the topic of cardiovascular disease</a> The decline in cardiovascular diseases. <a href="https://notes.llgoewer.de/s/DUMcPdcKK">Cardiovascular Disease Feet</a> <a href="https://hedgedoc.obco.pro/s/FUCRnbFcx">Medicines for kidneys-high blood pressure</a> <a href="https://pad.sra.uni-hannover.de/s/5HnAldweGs">Presentation on the topic of cardiovascular disease</a> <a href="https://hedgedoc.eclair.ec-lyon.fr/s/ETNbTuFQG">https://hedgedoc.eclair.ec-lyon.fr/s/ETNbTuFQG</a> <a href="https://www.notizen.kita.bayern/s/V57OEo835J">https://www.notizen.kita.bayern/s/V57OEo835J</a> <a href="https://md.eris.cc/s/XnBg1JgIcI">https://md.eris.cc/s/XnBg1JgIcI</a> <a href="https://hack.utopia-lab.org/s/ME2rfXp25">https://hack.utopia-lab.org/s/ME2rfXp25</a> <a href="https://md.gafert.org/s/FUDja33Zu">https://md.gafert.org/s/FUDja33Zu</a> <a href="https://doc.fung.uy/s/mF2p8KMdVq">https://doc.fung.uy/s/mF2p8KMdVq</a> <a href="https://md.micronited.de/s/BkPOIYgXGe">https://md.micronited.de/s/BkPOIYgXGe</a> <a href="https://pad.gusted.xyz/s/eSG3dFMwl">https://pad.gusted.xyz/s/eSG3dFMwl</a> <a href="https://hedgedoc.et.aksw.org/s/SF2IZK2eq">https://hedgedoc.et.aksw.org/s/SF2IZK2eq</a> <a href="https://n.jo-so.de/s/bXIiAbwCj">https://n.jo-so.de/s/bXIiAbwCj</a> <a href="https://hdoc.csirt-tooling.org/s/b-TAuhF9oi">https://hdoc.csirt-tooling.org/s/b-TAuhF9oi</a> <a href="https://codi.sevenvm.de/s/1jbqY8gII">https://codi.sevenvm.de/s/1jbqY8gII</a> <a href="https://md.softwarefreedom.net/s/EDhqITMef">https://md.softwarefreedom.net/s/EDhqITMef</a> <a href="https://doc.gnuragist.es/s/31KB7iPxjT">https://doc.gnuragist.es/s/31KB7iPxjT</a> <a href="https://hedgedoc.team23.org/s/vXGP1jEqys">https://hedgedoc.team23.org/s/vXGP1jEqys</a> <a href="https://hedge.amosamos.net/s/ULSb1K3cxD">https://hedge.amosamos.net/s/ULSb1K3cxD</a> <a href="https://pad.medialepfade.net/s/ZpqIsvvN9">https://pad.medialepfade.net/s/ZpqIsvvN9</a> <a href="https://pads.tobast.fr/s/zj-AKyW-PR">https://pads.tobast.fr/s/zj-AKyW-PR</a> <a href="https://pad.mytga.de/s/CppIwtuEc">https://pad.mytga.de/s/CppIwtuEc</a> <a href="https://om-office.de/s/r1wqUKl7Gl">https://om-office.de/s/r1wqUKl7Gl</a> <a href="https://docs.localcharts.org/s/tZ2wjgSr-">https://docs.localcharts.org/s/tZ2wjgSr-</a> <a href="https://pad.fablab-siegen.de/s/djyJcebPij">https://pad.fablab-siegen.de/s/djyJcebPij</a> <a href="https://md.giplt.nl/s/UOLaHR_Mhh">https://md.giplt.nl/s/UOLaHR_Mhh</a> <a href="https://doc.neutrinet.be/s/EXgwSDerTg">https://doc.neutrinet.be/s/EXgwSDerTg</a> <a href="https://pad.nantes.cloud/s/-f416XetlT">https://pad.nantes.cloud/s/-f416XetlT</a> <a href="https://doc.interscalar.eu/s/xSBTmV-OU">https://doc.interscalar.eu/s/xSBTmV-OU</a> <a href="https://doc.interscalar.eu/s/7lEVal4O1">https://doc.interscalar.eu/s/7lEVal4O1</a> <a href="https://md.globenet.org/s/KX-zWyTsw">https://md.globenet.org/s/KX-zWyTsw</a> <a href="https://md.interhacker.space/s/g9DamKSx5">https://md.interhacker.space/s/g9DamKSx5</a> <a href="https://doc.fsr.saarland/s/2b0WylMlnT">https://doc.fsr.saarland/s/2b0WylMlnT</a> <a href="https://notas.laotra.red/s/1V26XjqVSN">https://notas.laotra.red/s/1V26XjqVSN</a> <a href="https://hedgedoc.jcg.re/s/AmLe9phsAz">https://hedgedoc.jcg.re/s/AmLe9phsAz</a> <a href="https://doc.projectsegfau.lt/s/uM3y5ub3sS">https://doc.projectsegfau.lt/s/uM3y5ub3sS</a> <a href="https://hedgedoc.ffmuc.net/s/wB5A_yh55N">https://hedgedoc.ffmuc.net/s/wB5A_yh55N</a> <a href="https://doc.hkispace.com/s/Qa0toz9mU">https://doc.hkispace.com/s/Qa0toz9mU</a> <a href="https://pad.aleph.world/s/o2g4j-N5O">https://pad.aleph.world/s/o2g4j-N5O</a> <a href="https://docs.snowdrift.coop/s/InKYd4qyG">https://docs.snowdrift.coop/s/InKYd4qyG</a> <a href="https://pad.mytga.de/s/Ta2X-b2f4">https://pad.mytga.de/s/Ta2X-b2f4</a> <a href="https://hedgedoc.obco.pro/s/q_zpUH7oi">https://hedgedoc.obco.pro/s/q_zpUH7oi</a> <a href="https://pad.sra.uni-hannover.de/s/SgwxB0VnMr">https://pad.sra.uni-hannover.de/s/SgwxB0VnMr</a> <a href="https://md.coredump.ch/s/yKUfKl-Ys">https://md.coredump.ch/s/yKUfKl-Ys</a> <a href="https://pad.koeln.ccc.de/s/Xck5VL1qQ">https://pad.koeln.ccc.de/s/Xck5VL1qQ</a> <a href="https://hedgedoc.ichmann.de/s/f0cz_DXSDa">https://hedgedoc.ichmann.de/s/f0cz_DXSDa</a> <a href="https://notes.llgoewer.de/s/u8Mm9coHV">https://notes.llgoewer.de/s/u8Mm9coHV</a> <a href="https://pad.ccc-p.org/s/L92EE7FegS">https://pad.ccc-p.org/s/L92EE7FegS</a> <a href="https://md.nolog.cz/s/lkjUV3SYH">https://md.nolog.cz/s/lkjUV3SYH</a> <a href="https://md.infs.ch/s/huoj80t0Jm">https://md.infs.ch/s/huoj80t0Jm</a> <a href="https://hedgedoc.private.coffee/s/UFn9GY5UP">https://hedgedoc.private.coffee/s/UFn9GY5UP</a> <a href="https://md.sebastians.dev/s/OCONy7UVy">https://md.sebastians.dev/s/OCONy7UVy</a> <a href="https://pad.yuka.dev/s/o3xqdDasjN">https://pad.yuka.dev/s/o3xqdDasjN</a> <a href="https://doc.hkispace.com/s/C2ieATKmA">https://doc.hkispace.com/s/C2ieATKmA</a> <a href="https://pad.multiplace.org/s/rkukvFxmMl">https://pad.multiplace.org/s/rkukvFxmMl</a> <a href="https://pad.demokratie-dialog.de/s/c-oorDBWu-">https://pad.demokratie-dialog.de/s/c-oorDBWu-</a> <a href="https://hedgedoc.inqbus.de/s/4rNJAfHLu">https://hedgedoc.inqbus.de/s/4rNJAfHLu</a> <a href="https://md.cortext.net/s/ayTSl77yv">https://md.cortext.net/s/ayTSl77yv</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/52o4cOOMDs">https://hedgedoc.stanleysolutionsnw.com/s/52o4cOOMDs</a> <a href="https://omoffice.de/s/B14gPKlmzl">https://omoffice.de/s/B14gPKlmzl</a> <a href="https://md.sigma2.no/s/5YftXXz-N">https://md.sigma2.no/s/5YftXXz-N</a> <a href="https://md.coredump.ch/s/Xe6QHO5SE">https://md.coredump.ch/s/Xe6QHO5SE</a> <a href="https://doc.cisti.org/s/HAzzpIlKLk">https://doc.cisti.org/s/HAzzpIlKLk</a> <a href="https://pad.n39.eu/s/Ti-_LLv28o">https://pad.n39.eu/s/Ti-_LLv28o</a> <a href="https://edit.leiden.digital/s/bW-K0XDdTx">https://edit.leiden.digital/s/bW-K0XDdTx</a> <a href="https://doc.spiegie.de/s/neFTH4l5Z">https://doc.spiegie.de/s/neFTH4l5Z</a> <a href="https://notas.gaiacoop.tech/s/iYlHetdqg">https://notas.gaiacoop.tech/s/iYlHetdqg</a> <a href="https://hd.wedler.me/s/IihIySYmY">https://hd.wedler.me/s/IihIySYmY</a> <a href="https://www.notizen.kita.bayern/s/i3MPedVYth">https://www.notizen.kita.bayern/s/i3MPedVYth</a> <a href="https://hedgedoc.digilol.net/s/18MLoKzShc">https://hedgedoc.digilol.net/s/18MLoKzShc</a> <a href="https://hedgedoc.private.coffee/s/k2Q_oKGbe">https://hedgedoc.private.coffee/s/k2Q_oKGbe</a> <a href="https://notes.simeonreusch.com/s/jEWyBT-qp">https://notes.simeonreusch.com/s/jEWyBT-qp</a> <a href="https://hedgedoc.syyrell.com/s/OWBstzC95f">https://hedgedoc.syyrell.com/s/OWBstzC95f</a> <a href="https://pad.cttue.de/s/Unc3lXJ_W">https://pad.cttue.de/s/Unc3lXJ_W</a> <a href="https://md.mandragot.org/s/w1p_l5sGs1">https://md.mandragot.org/s/w1p_l5sGs1</a> <a href="https://pads.cantorgymnasium.de/s/psEPWg-dB">https://pads.cantorgymnasium.de/s/psEPWg-dB</a> <a href="https://pad.gusted.xyz/s/_Ej84M6Qk">https://pad.gusted.xyz/s/_Ej84M6Qk</a> <a href="https://hedgedoc.et.aksw.org/s/qa9uYgCMk">https://hedgedoc.et.aksw.org/s/qa9uYgCMk</a> <a href="https://write.frame.gargantext.org/s/rJdJSYx7Mx">https://write.frame.gargantext.org/s/rJdJSYx7Mx</a> <a href="https://pads.dgnum.eu/s/xx6Te9rrmj">https://pads.dgnum.eu/s/xx6Te9rrmj</a> <a href="https://hedgedoc.nrp-nautilus.io/s/9fFVXgcPvR">https://hedgedoc.nrp-nautilus.io/s/9fFVXgcPvR</a> <a href="https://notes.rabjerg.de/s/rJHUDFxQGl">https://notes.rabjerg.de/s/rJHUDFxQGl</a> <a href="https://pad.medialepfade.net/s/0jExj3BaJ">https://pad.medialepfade.net/s/0jExj3BaJ</a> <a href="https://hedgedoc.obermui.de/s/0_ZCf2F_NX">https://hedgedoc.obermui.de/s/0_ZCf2F_NX</a> <a href="https://pad.dominick-leppich.de/s/A9XuPflp3">https://pad.dominick-leppich.de/s/A9XuPflp3</a> <a href="https://hedgedoc.auro.re/s/M6-1EEme_T">https://hedgedoc.auro.re/s/M6-1EEme_T</a> ## Presentation on the topic of cardiovascular disease ## presentation: cardiovascular disease — causes, risk factors, and prevention Slide 1: Title Cardiovascular diseases: A global health challenge Slide 2: Introduction Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. According to the world health organization (WHO), every year approximately 17.9 million deaths, equivalent to approximately 32% of all deaths worldwide. The aim of this presentation: Definition and classification of CVD The main causes and risk factors Diagnostic Procedures Preventive measures and therapeutic approaches Slide 3: Definition and classification Cardiovascular diseases are a group of diseases that affect the heart and blood vessel system. Important Sub-Groups: Coronary heart disease (CHD): narrowing of the coronary arteries by atherosclerosis Heart failure: Decreased contractile capacity of the heart Arrhythmias: heart rhythm disorders High blood pressure (hypertension): Permanently elevated blood pressure (≥140/90 mmHg) Stroke (apoplexy): circulatory disorder in the brain Peripheral arterial occlusive disease (paod): constriction in the blood vessels of the extremities Slide 4: causes and Pathomechanisms Main mechanism: atherosclerosis — deposition of lipids, calcium, and fibrous tissue in the vessel wall. Process flow: Endothelial damage (e.g., hypertension, Smoking) Lipid entry into the vessel wall The formation of a Plaque (vasoconstriction) Possible plaque rupture → thrombus formation → heart attack or stroke Other Causes: Genetic Disposition Inflammatory Processes Autoimmune reactions Slide 5: Modifiable and non-modifiable risk factors Modifiable Not modifiable Smoking age (45 J. in men, and from 55 for women) Overweight / obesity (BMI ≥30 kg/m 2 ), Gender (men are more frequently affected) Lack Of Exercise, Family History Of Unbalanced diet (high, high salt and fat content) Genetic factors Hypertension Diabetes mellitus Elevated cholesterol levels (LDL &gt;3.0 mmol/l) Slide 6: Diagnostics Standard methods for the detection of CVD: ECG (electrocardiogram): recording of the electrical activity of the heart Echocardiography: ultrasound for the assessment of cardiac structure and function Long‑term ECG / long‑term blood pressure measurement: detection of rhythmic and blood pressure-related changes in 24 hours Exercise ECG (game gears‑Test): testing under physical stress Coronary angiography: x-ray examination of the heart arteries with contrast medium Laboratory parameters: lipid spectrum, CRP, Troponin (when infarction is suspected) Slide 7: Approaches To Therapy Drug Therapy: Antihypertensives (e.g., ACE inhibitors, beta-blockers) Statins for lowering cholesterol Anticoagulants (for example, acetylsalicylic acid) Diuretics in heart failure Interventional Procedures: PTCA (balloon dilatation with Stent) Bypass Surgery Lifestyle changes: Smoking abstinence Balanced diet (DASH diet, Mediterranean cost) Regular physical activity (min. 150 Minutes/Week) Weight control Slide 8: prevention — the key to the reduction of CVD Primary prevention is more effective and more cost-effective than the treatment of the advanced disease. Recommended Action: Regular health examinations from 35 years of age (early risk detection) Blood pressure and cholesterol control Promotion of health awareness in schools and in the workplace Policy measures (e.g. salt reduction in processed foods, tobacco control laws) Slide 9: Summary Cardiovascular diseases represent a serious global health threat. Atherosclerosis is the main pathophysiological mechanism. Many risk factors are modifiable. Early detection and prevention can reduce deaths significantly. A holistic approach (medical, social, political) is necessary. Slide 10: Acknowledgements and questions Many thanks for your attention! Questions and discussion are welcome.